Economic Chapter 1: The Research and Development of Innovative Drugs Is An Economic Activity With Scientific And Engineering Attributes
"The term "Economy" is used to collectively refer to the system that organizes production, distribution, circulation, consumption activities and relationships within a certain scope (country, region, etc.), usually with money as the medium and goods or services as the result."
"Science is a systematic knowledge system that accumulates, organizes and can test explanations and predictions about all things."
"Engineering refers to the process in which humans use scientific principles and technical means to solve practical problems. It is a systematic, purposeful, planned, organized, and economic activity whose purpose is to achieve some kind of goal to meet people's needs."
The research and development of innovative drugs is an economic activity with scientific and engineering attributes: various economic entities involved in the research and development of innovative drugs organize the research and development of innovative drugs to achieve the goal of making profits or improving public health; In the process of research and development of innovative drugs, explanations related to the development and treatment of diseases can be accumulated and tested, and to a certain extent, the impact of certain drugs and treatments on some disease processes can be predicted, and contribution can be made to science. On the other hand, the construction of pharmaceutical factories, the mass production of innovative drugs, and the organization and implementation of clinical trials all have strong engineering attributes.
The economic chapters on innovative drug research and development will cover the following categories, which will be further expanded on in subsequent chapters:
1 Innovative drugs and economic development stages (in social and historical perspectives)
2 Major countries and regions (USA, Europe, Japan, China, etc.)
3 Various economic entities involved in the research and development of innovative drugs (pharmaceutical companies, biotechnology companies, CROs, hospitals, universities and scientific research institutions, insurance companies, patent and law firms, investment institutions, government and regulatory authorities, etc.)
4 Sales and Pricing of Innovative Drugs
5 Patent protection system
6 Financial investment
